Optimal Duration of Dual Antiplatelet Therapy after Drug‐Eluting Stents: Meta‐Analysis of Randomized Trials

Publisher： John Wiley & Sons Inc

E-ISSN： 1755-5922|33|5|253-263

ISSN： 1755-5914

Source： CARDIOVASCULAR THERAPEUTICS (ELECTRONIC), Vol.33, Iss.5, 2015-10, pp. : 253-263

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Comparison between Drug-Eluting Stents and Coronary Artery Bypass Grafting for Unprotected Left Main Coronary Artery Disease: A Meta-Analysis of Two Randomized Trials and Thirteen Observational Studies

By  

Cardiology, Vol. 118, Iss. 1, 2011-03 ,pp. : 22-32

Karger

Access to resources Recommend Favorite

Meta-Analysis of Trials Comparing Oral Anticoagulation and Aspirin versus Dual Antiplatelet Therapy after Coronary Stenting

By  

Cardiology, Vol. 104, Iss. 2, 2005-08 ,pp. : 101-106

Karger

Access to resources Recommend Favorite

Stent Thrombosis with Biodegradable Polymer Drug-Eluting Stents versus Durable Polymer Sirolimus-Eluting Stents: An Update Meta-Analysis

By  

Cardiology, Vol. 130, Iss. 2, 2015-01 ,pp. : 96-105

Karger

Access to resources Recommend Favorite

Clinical outcome of DES versus BMS

By  

INTERNAL MEDICINE JOURNAL, Vol. 45, Iss. 2, 2015-02 ,pp. : 203-211

John Wiley & Sons Inc

Access to resources Recommend Favorite

The Dual Antiplatelet Therapy Trial after the FDA Update: Noncardiovascular Deaths, Cancer and Optimal Treatment Duration

By  

Cardiology, Vol. 132, Iss. 2, 2015-06 ,pp. : 74-80

Karger

Access to resources Recommend Favorite